Fullife Healthcare Raises ₹300 Crore in Series D Funding Led by Elev8

Fullife Healthcare has raised ₹300 crore in a Series D funding round led by Elev8 Venture Partners. The funding was announced on March 26, 2026, marking a significant capital infusion for the health and wellness company.

The company did not disclose its valuation or the stake acquired in the transaction. The development reflects continued investor interest in India’s growing direct-to-consumer (D2C) nutrition segment.

Funding Details and Investor Participation

The Series D round was led by Elev8 Venture Partners, a Bengaluru-based investment firm. This marks Elev8’s first investment in the D2C segment and its sixth deal from the current fund.

The investor highlighted a structural shift in consumer behaviour as a key reason for entering this space. The absence of disclosed valuation indicates limited public details on deal pricing and ownership dilution.

Company Profile and Brand Portfolio

Fullife Healthcare operates in the health and nutrition segment with a focus on consumer wellness products. The company owns brands such as Fast&Up and Chicnutrix, which cater to hydration, fitness, and beauty nutrition categories.

It has built a presence across multiple consumer segments through targeted product offerings. The company has reported profitability in its existing core segments.

Growth Strategy and Expansion Plans

The company plans to deploy the newly raised capital to expand into high-growth nutrition categories. Key focus areas include digestive health, sleep support, and protein-based nutrition products.

These segments are witnessing rising consumer demand driven by increasing health awareness. The expansion strategy also aligns with broader trends in preventive healthcare and lifestyle-based nutrition.

Global Presence and Funding History

Fullife Healthcare currently operates in 40 international markets, including the US, UK, and Gulf region. The company intends to deepen its presence in these geographies as part of its growth roadmap.

Prior to this round, it had raised $46.1 million across 8 funding rounds since its inception in 2011. Its previous Series C round in 2021 and was led by Morgan Stanley Private Equity Asia, with participation from other notable investors.

Read More: Quick Home Services Startup Pronto Secures $25 Million in Series B Funding Round.

Conclusion

The ₹300 crore Series D funding marks a key milestone for Fullife Healthcare in its growth journey. The investment signals increasing investor confidence in the D2C nutrition and wellness space.

With plans to expand product categories and strengthen global operations, the company is positioning itself for further scale. The development reflects broader trends in health-focused consumer spending and international market expansion.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.